前庭神经鞘瘤恶变为恶性外周神经鞘瘤的系统综述与汇总分析
从VS诊断到MPNST的中位间隔为54.0个月,75%有既往放疗史;全部患者接受 resection,42%接受辅助放疗,中位总生存11.0个月,辅助放疗与更长生存相关(15.6 vs. 4.0个月,p<0.001)。
要点
- VS恶变为MPNST罕见,多发生于既往放疗后,中位间隔54.0个月。
- 全部患者接受 resection,42%接受辅助放疗,中位总生存仅11.0个月。
- 辅助放疗与更长总生存相关(15.6 vs. 4.0个月,p<0.001)。
核心结论
- VS恶变为MPNST后生存预后差,中位总生存11.0个月。
- 早期手术干预和辅助放疗可能带来生存获益,尽管复发风险高。
研究设计与样本
- PRISMA指导的系统综述,检索PubMed、Scopus和Google Scholar数据库。
主要发现
- 24例患者中7例男性,中位年龄52岁,8%为神经纤维瘤病2型相关神经鞘瘤病。
- 从VS到MPNST诊断的中位间隔为54.0个月,75%患者有既往放疗史。
- 自发恶变患者的中位间隔显著短于放疗后恶变者(7.2 vs. 84.0个月,p=0.001)。
- 全部患者恶变后接受 resection,42%接受辅助放疗;中位总生存11.0个月。
- 辅助放疗与更长总生存相关(15.6 vs. 4.0个月,p<0.001);可评估患者中60%出现复发或进展。
关键数值与推荐
- 自发恶变与放疗后恶变的中位间隔分别为7.2个月和84.0个月(p=0.001)。
- 辅助放疗组与未放疗组的中位总生存分别为15.6个月和4.0个月(p<0.001)。
- 诊断年龄、性别、肿瘤大小、侧别、p53状态和脑积水发生与总生存无统计学显著差异。
临床怎么用
- 对VS恶变为MPNST患者应尽早行手术 resection。
- 术后可考虑辅助放疗以延长总生存。
- 需警惕高复发风险,可评估患者中60%出现复发或进展。
局限性
- 证据仅来自病例报告和病例系列,样本量小(24例)。
- 部分变量(如p53状态、脑积水)数据可能不完整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Transformation of vestibular schwannoma (VS) into malignant peripheral nerve sheath tumor (MPNST) is rare and poorly characterized. We have synthesized available evidence from the literature to define clinical features, transformation patterns, management strategies, and survival outcomes in patients with MPNST after histologically confirmed transformation from VS. METHODS: A PRISMA-guided systematic review of PubMed, Scopus, and Google Scholar databases identified case reports and case series reporting histologically confirmed VSs transforming to MPNSTs with clinical and outcome data. Demographic, clinical, treatment, and survival variables were extracted and analyzed. RESULTS: Twenty-one studies comprised 24 patients (7 male) with MPNSTs (median age 52 years; 8% with neurofibromatosis 2-related schwannomatosis). The median interval from VS to MPNST diagnosis was 54.0 months; 75% of patients had prior radiation-based therapy for VS. The transformation interval was significantly shorter in patients with spontaneous transformation compared with those whose transformation occurred after radiation (7.2 vs. 84.0 months; p = 0.001). All patients underwent resection after their tumors transformed into MPNST; 42% received adjuvant radiation-based therapy. Median overall survival was 11.0 months, and adjuvant radiation-based therapy was associated with longer overall survival (15.6 vs. 4.0 months; p < 0.001) in all patients with MPNST. Age at diagnosis, sex, tumor size, tumor laterality, p53 status, and hydrocephalus occurrence were not associated with a statistically significant difference in overall survival. Recurrence or progression occurred in 60% of evaluable patients. CONCLUSION: Once transformation of VS into MPNST occurs, survival prognosis is bleak; however, these results indicate that early surgical intervention and adjunctive radiation-based therapy for MPNST may offer survival benefits despite high recurrence risk.
引用
- Bin-Alamer O, Haider MA, Balasubramanian K, et al. Transformation of vestibular schwannomas into malignant peripheral sheath tumors: a systematic review and pooled analysis of patient characteristics and survival outcomes. J Neurooncol. 2026. PMID: 42599576. doi:10.1007/s11060-026-05722-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。